Skip to main content
Premium Trial:

Request an Annual Quote

Ezose Sciences, Kyowa Hakko Ink Glycomics Pact

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement to collaborate with Kyowa Hakko Kirin on glycomics studies using Ezose's GlycanMap platform.

Under terms of the deal, Kyowa Hakko Kirin will provide funding for several glycan biomarker efforts and other discovery projects, said Pine Brook, NJ-based Ezose. Financial and other terms of the collaboration were not disclosed.

Ezose's GlycanMap platform combines MALDI-TOF mass spectrometry with bioinformatics to structurally identify and quantitate glycans present in complex biological samples. The glycans can be used in developing therapeutics or diagnostics, including companion diagnostics, said Ezose.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.